Skip to main content
Premium Trial:

Request an Annual Quote

Top 10 Most Viewed Articles on GWDN in 2013

NEW YORK (GenomeWeb News) – Reorganizations, industry acquisitions, US Food and Drug Administration action on direct-to-consumer genomics, and the end of a partnership were among the topics that drew the most interest from readers in 2013.

Below is the list of the 10 articles our readers viewed the most during the year on GenomeWeb Daily News.

1) Roche Shutting Down 454 Sequencing Business
2) Thermo Fisher Buying Life Technologies for $13.6B
3) FDA Tells 23andMe to Halt Marketing Personal Genome Service
4) Life Technologies' Stock Jumps on Reports of Potential Leveraged Buyout or Sale
5) Roche to Shut Down Applied Sciences Business Area, Cut Jobs in Germany and Connecticut
6) Oxford Nanopore, Illumina to Cut Ties
7) Organizational Changes at Illumina Aimed at Growth, New Market Entries
8) Class Action Lawsuit Seeks to Stop Thermo Fisher's $13.6B Buy of Life Tech
9) Class Action Suit Filed Against 23andMe
10) Qiagen Acquires CLC Bio

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.